NCT00311688View on ClinicalTrials.gov

Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies

CompletedOBSERVATIONAL
Timeline

Start Date

December 31, 2003

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
HIV Infections
Interventions
DRUG

Interleukin-2

Biological response modifier in liquid form; dosage of drug will vary by study

Trial Locations (1)

20892

NIH Intramural Research Program ACTG CRS, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00311688 - Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies | Biotech Hunter | Biotech Hunter